“Circulating Fibroblast Growth Factor-23 Is Associated With Increased Risk for Metachronous Colorectal Adenoma”. Journal of Carcinogenesis, vol. 10, no. 1, Feb. 2011, https://carcinogenesis.com/index.php/JOC/article/view/146.